About the Authors
- Amanda Mocroft
-
* E-mail: a.mocroft@ucl.ac.uk
Affiliation Department of Infection and Population Health, University College London, London, United Kingdom
- Jens D. Lundgren
-
Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- Michael Ross
-
Affiliation Division of Nephrology, Mount Sinai School of Medicine, New York, New York, United States of America
- Matthew Law
-
Affiliation The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
- Peter Reiss
-
Affiliation Division of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Ole Kirk
-
Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- Colette Smith
-
Affiliation Department of Infection and Population Health, University College London, London, United Kingdom
- Deborah Wentworth
-
Affiliation University of Minnesota, Minneapolis, Minnesota, United States of America
- Jacqueline Neuhaus
-
Affiliation University of Minnesota, Minneapolis, Minnesota, United States of America
- Christoph A. Fux
-
Affiliation Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland
- Olivier Moranne
-
Affiliation Nephrology Department, Public Health Department, Centre Hospitalier Universitaire de Nice, Nice, France
- Phillipe Morlat
-
Affiliation Université de Bordeaux, INSERM U 897, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
- Margaret A. Johnson
-
Affiliation Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom
- Lene Ryom
-
Affiliation Copenhagen HIV Programme, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups
-
¶Membership of the D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups is listed in the Acknowledgments.
Competing Interests
PM: honoraria or travel/meeting expenses from Bristol-Myers Squibb, Gilead, Janssen-Cilag, Merck Sharp & Dohme-Chibret and ViiV Healthcare in the past five years. ML received unrestricted grants to my institution from Boehringer Ingelhiem, Gilead Sciences, Merck Sharp & Dohme, Bristol-Myers Squibb, Janssen-Cilag, ViiV HealthCare. CS has received funds for preparation of Educational Materials from Janssen, Gilead, BMS, ViiV HealthCare, support for attendance at Ad board and support to attend HIV conference from Gilead, funding to conduct study from BMS. OM has received honoraria as a speaker from Abbott and Gilead Sciences, serves on the board of Roche, and had expenses paid by Roche and Baxter for travel, accommodations, and meetings. OK has received honoraria, consultancy, lecture fees, and travel grants from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck Sharp & Dohme, Roche, and ViiV Healthcare, and has served/is serving on Advisory Boards for Gilead Sciences, Merck Sharp & Dohme, and ViiV Healthcare. AM has received honoraria, consultancy, lecture fees, and travel grants from Gilead Sciences, Merck Sharp & Dohme, Boehringer Ingelheim, Pfizer and GSK.
Author Contributions
Conceived and designed the experiments: AM JDL OK LR. Performed the experiments: AM JDL OK LR. Analyzed the data: AM. Enrolled patients: ML PR OK CS DW JN CAF OM PM MAJ. Wrote the first draft of the manuscript: AM JDL LR. Wrote the paper: AM JDL MR ML PR OK CS DW JN CAF OM PM MAJ LR. Agree with manuscript results and conclusions: AM JDL MR ML PR OK CS DW JN CAF OM PM MAJ LR. All authors have read, and confirm that they meet, ICMJE criteria for authorship.